Caris Life Sciences Launches Groundbreaking Whole Genome and Transcriptome Profiling Assay for Myeloid Cancers Caris Life Sciences has unveiled ChromoSeq, a pioneering assay for comprehensive profiling of myeloid malignancies, enhancing precision in cancer treatment.

Caris Life Sciences Launches Groundbreaking Whole Genome and Transcriptome Profiling Assay for Myeloid Cancers #United_States #Caris_Life_Sciences #Irving #Caris_ChromoSeq #Myeloid_Malignancies